The development of these materials addresses a longstanding challenge in biomedical optics: achieving deep tissue imaging with minimal phototoxicity and background noise. Traditional fluorescence imaging often relies on ultraviolet or blue light excitation, which suffers from limited tissue penetration and can induce cellular damage. By contrast, red and near-infrared light sources offer greater penetration and lower phototoxicity, but engineering organic materials that respond efficiently to such excitation while providing sustained afterglow has proven elusive—until now.

Central to the study is the creation of organic afterglow materials that are dynamically excitable by red light, enabling persistent near-infrared emission. This long-lived luminescence after cessation of excitation circumvents real-time excitation challenges, substantially reducing autofluorescence and scattering problems commonly faced in live tissues. The materials’ organic nature also circumvents potential biocompatibility concerns associated with heavy-metal-based inorganic phosphors, making them particularly suited for in vivo applications.

The researchers employed an innovative molecular design strategy that integrates specific chromophores with optimized energy states to facilitate efficient triplet harvesting and intersystem crossing. By finely tuning molecular structures, they achieved an organic afterglow system capable of robust red-light excitation, which then produces prolonged NIR emission. This dual-wavelength functionality is crucial for penetrating biological tissues and capturing high-contrast images over extended periods.

Detailed photophysical analyses revealed that these materials exhibit impressive afterglow lifetimes spanning seconds to minutes, maintaining emission intensity well beyond the duration of excitation. Such extended afterglow behavior is instrumental for practical imaging since it allows temporal separation between excitation and signal acquisition, thereby eliminating background fluorescence and enhancing signal-to-noise ratios.

Beyond their remarkable luminescence characteristics, these organic afterglow materials demonstrate excellent biocompatibility and stability in physiological environments. The team conducted extensive in vivo experiments to evaluate bioimaging performance, leveraging small animal models to visualize biological structures with unprecedented clarity and depth. The materials’ dynamic excitation capability permitted selective imaging of tissues without continuous light exposure, mitigating heat generation and photodamage risks.

One of the striking demonstrations involved tracking tumor tissues in live animals, where the afterglow probes illuminated cancerous regions with high spatial resolution and low invasiveness. This breakthrough suggests a powerful tool for early cancer detection and monitoring therapeutic responses, leveraging the materials’ capacity for deep tissue visualization without reliance on external dyes or radioactive tracers.

Moreover, the study highlights the tunability of these afterglow systems, suggesting future avenues for custom designing materials tailored for specific wavelengths or targeting capabilities. This versatility could pave the way for multiplexed imaging platforms, combining multiple organic afterglow probes to monitor diverse biological processes simultaneously with minimal crosstalk.

The energy-efficient nature of the red-light excitation mechanism also holds great promise for portable and wearable biosensors. Unlike conventional fluorescence methodologies demanding bulky and energy-intensive excitation sources, these materials require only low-intensity red light to trigger sustained NIR emission, potentially enabling compact, battery-powered imaging devices for point-of-care diagnostics.

The researchers also emphasize the implications for longitudinal biological studies. Because the afterglow emission persists after excitation has ended, repetitive imaging sessions can be conducted with minimal disturbance to the subject, enhancing the feasibility of real-time monitoring of dynamic physiological changes or disease progression in live organisms.

On the technical front, the molecular architecture involves carefully balancing intersystem crossing efficiency with triplet state stabilization, ensuring prolonged phosphorescence without compromising emission brightness. Advanced spectroscopic techniques confirmed the materials’ unique dynamic excitation behavior, elucidating the underlying photophysical mechanisms that differentiate them from conventional fluorescent or phosphorescent probes.

From a materials science perspective, the synthesis protocols prioritize scalability and cost-effectiveness, employing organic components readily available and amenable to modification. This practical approach is expected to accelerate translation from laboratory research to commercial biomedical imaging applications.

The study’s coherent integration of chemistry, photophysics, and biomedical engineering sets a benchmark for future research aiming to harness organic afterglow materials for clinical and research-oriented bioimaging. The ability to safely and effectively image deep tissues through red-light activation and NIR emission promises to enhance diagnostic accuracy, therapeutic monitoring, and even guided surgery procedures.

Furthermore, ethical and safety assessments conducted alongside the imaging trials confirmed negligible cytotoxic effects and minimal immune responses, underscoring the suitability of these organic afterglow materials for repeated use in living subjects.

In conclusion, the work of Zhou and colleagues significantly broadens the toolkit for non-invasive biological imaging by combining the advantages of red-light excitation and dynamic NIR afterglow emission within organic molecular frameworks. Their findings are poised to inspire a new wave of innovations in biosensing, enabling clinicians and researchers to peer deeper into living systems with unprecedented clarity, safety, and temporal flexibility.

This breakthrough not only advances fundamental knowledge in organic luminescent materials but also underscores the critical role of interdisciplinary collaborations in addressing complex biomedical challenges. As ongoing research refines these materials and integrates them into multifunctional imaging platforms, the future of bioimaging promises to be brighter, deeper, and more insightful than ever before.

Subject of Research: Development of red-light-excited dynamic near-infrared organic afterglow materials for in vivo bioimaging.

Article Title: Red-light-excited dynamic near-infrared organic afterglow materials for in vivo bioimaging.

Article References:
Zhou, L., Yang, J., He, Z. et al. Red-light-excited dynamic near-infrared organic afterglow materials for in vivo bioimaging. Light Sci Appl 15, 271 (2026). https://doi.org/10.1038/s41377-026-02340-3

Image Credits: AI Generated

DOI: 10 June 2026

Obesity has long been recognized as a multifaceted disease that disrupts not only fat accumulation but also touches every physiological system from immunity to neural networks. Traditional research methods have been constrained by the limited scope of tissue analysis, generally focusing on isolated organs without capturing the full syndrome’s complexity. MouseMapper transcends these barriers by enabling seamless, high-resolution examination of entire organisms, linking molecular, cellular, and tissue-level changes within a single analytical framework.

At the core of MouseMapper is a foundation-model-based suite of deep neural networks designed to segment and analyze whole-body biological imaging datasets. This system can identify 31 different organs and tissue types while simultaneously mapping nerve fibers and immune cell populations with cellular precision. Unlike conventional machine learning tools, MouseMapper exhibits remarkable generalizability, allowing it to adapt to diverse datasets beyond its initial training regime. Such flexibility positions it as a versatile tool for investigating a wide range of systemic diseases.

The researchers employed fluorescent markers targeting nerves and immune cells in mice, followed by advanced tissue-clearing protocols to render the entire body transparent without compromising biomarker integrity. This was coupled with light-sheet microscopy—a state-of-the-art imaging modality capable of capturing three-dimensional volumetric data at cellular resolution. Through this approach, the team generated exhaustive datasets containing tens of millions of cellular structures, encompassing organs from adipose tissue to peripheral nerves.

MouseMapper automated the segmentation and quantitative analysis of these massive datasets, enabling an unbiased survey of inflammation and nerve remodeling throughout the mouse anatomy. In studying obesity, it uncovered widespread alterations in immune-cell clustering and a striking degenerative reorganization of the trigeminal nerve—a critical facial nerve responsible for sensory and motor functions. Obese mice displayed significantly diminished nerve branching and endings in this region, correlating with reduced sensory responsiveness in behavioral assays.

To investigate molecular underpinnings of these structural changes, the team examined the trigeminal ganglion, the neuronal hub containing sensory neuron cell bodies. Spatial proteomics analyses revealed distinct signatures of nerve remodeling and local inflammation. Remarkably, parallel molecular alterations were identified in human trigeminal tissue samples from individuals with obesity, strongly suggesting evolutionary conservation of obesity-induced neural pathologies across species.

This discovery opens new vistas into the concealed neuronal dysfunctions linked to metabolic disease, highlighting the critical need to adopt holistic investigative approaches capable of capturing disease dynamics at the organismal level. By revealing how obesity systematically remodels the nervous and immune systems, MouseMapper not only enriches our understanding of disease pathophysiology but also provides an invaluable resource for identifying new therapeutic targets.

Beyond shedding light on obesity, the implications of MouseMapper’s integrated analytical capabilities extend to a broad spectrum of complex diseases, including diabetes, cancer, neurodegenerative conditions, and autoimmune disorders. Its ability to generate unbiased, comprehensive maps of disease-related “hotspots” marks a paradigm shift from reductionist, organ-centric studies to systemic, multi-organ investigations that reflect the inherent complexity of biological systems.

Importantly, the research team has made these detailed whole-body datasets publicly accessible, fostering transparency and enabling scientists worldwide to interrogate obesity-associated cellular and structural changes across diverse tissues. This open-science approach accelerates collaborative discovery and amplifies the impact of their innovations.

Looking forward, Prof. Ali Ertürk, the project’s lead and Director of the Institute for Biological Intelligence at Helmholtz Munich, envisions an ambitious future where MouseMapper evolves into a foundational tool for creating digital twins of organisms. These virtual models, rendered at cellular resolution and infused with real-world biological data, promise to revolutionize disease modeling, drug development, and personalized medicine by permitting in silico experimentation that can anticipate and modulate disease trajectories with minimal reliance on physical trials.

This pioneering research thus sets the stage for a new era of intelligent biomedical exploration where artificial intelligence and high-resolution imaging converge to unravel the intricacies of systemic disease, transforming how scientists and clinicians understand, diagnose, and treat complex medical conditions in an interconnected physiological context.

Subject of Research: Whole-body cellular mapping and disease analysis using artificial intelligence in obesity

Article Title: AI Atlas Reveals Hidden Whole-Body-Damage Caused by Obesity

News Publication Date: 20-May-2026

Web References: DOI link to original publication

References: Kaltenecker et al., 2026: A deep-learning framework reveals whole-body perturbations at cell level. Nature. DOI: 10.1038/s41586-026-10535-2

Image Credits: Helmholtz Munich / Ertürk Lab

Keywords

Obesity, Artificial Intelligence, Metabolism, Neural Remodeling, Immune System, Deep Learning, Whole-body Imaging, Light-sheet Microscopy, Tissue Clearing, Trigeminal Nerve, Spatial Proteomics, Digital Twins

One such pioneering technique gaining traction is terahertz (THz) imaging, a non-invasive method that employs terahertz radiation for high-resolution visualization of biological tissues. Researchers from Waseda University and affiliated institutions have recently conducted groundbreaking studies demonstrating the potential of THz imaging in the visualization of cochlear architecture. Led by Associate Professor Kazunori Serita, this team has managed to use a micrometer-sized THz point source to investigate the internal structures of the cochlea in mice.

The cochlea is a small, spiral-shaped organ situated in the inner ear, responsible for converting sound waves into neural signals. Thus, understanding its structure is crucial for diagnosing various auditory disorders. The significance of a technique capable of visualizing the cochlea lies in its potential to revolutionize auditory diagnostics. By harnessing THz waves, scientists could achieve deeper tissue penetration and attain unprecedented levels of structural clarity, thereby allowing for accurate assessment and diagnosis of cochlear diseases.

Through innovative methodologies, the research team created micrometer-sized THz point sources utilizing femtosecond lasers, which emit pulses of light at a wavelength of 1.5 μm. This advanced setup not only enabled high-resolution visualization of cochlear structures but also facilitated near-field imaging by positioning the cochlea directly on a GaAs substrate. Such strategic placements optimize the imaging process, gathering comprehensive 2D THz time-domain images across a broad time spectrum, which ultimately results in detailed structural representation at varying depths.

To convert the captured time-domain images into accurate depth scales, the researchers utilized the time-of-flight principle. This crucial application means that every captured THz image corresponds with specific depth, transforming mere images into spatially meaningful data. In addition, the team incorporated k-means clustering, an unsupervised machine-learning method, to identify intricate structural features within the cochlea. The successful deployment of this technique resulted in a 3D reconstruction of the cochlea, culminating in a precise point cloud and surface mesh model that vividly represents the cochlear architecture.

The implications of this groundbreaking research are profound. The study conclusively affirmed the viability of THz imaging as a powerful diagnostic tool for the inner ear, offering detailed insights into cochlear intricacies. The ability to reconstruct 3D models significantly enhances scientific understanding of cochlear structures, a critical advancement for developing targeted treatments for hearing loss.

The potential of terahertz imaging does not merely end with cochlear diagnostics. The researchers speculate that this innovative imaging technique could evolve into miniaturized devices, such as terahertz endoscopes and otoscopes. Such advancements would enable real-time, in vivo imaging for a variety of applications, including dermatology and even early cancer detection. This multifaceted approach could usher in a new era of diagnostics, showcasing how integrating THz technology with existing medical imaging practices could dramatically change the landscape of disease diagnosis.

Moreover, THz technology promises to enhance the efficiency of pathological diagnoses. By significantly reducing the time necessary to conduct tests and receive results, healthcare providers can improve patient outcomes through timely interventions. This capability is particularly crucial in oncology and pathology, where the speed and accuracy of diagnosis correlate directly with treatment efficacy. As researchers continue to explore the possibilities of THz imaging, they recognize its capacity to complement and transform current methods of disease detection.

The collective findings of this study represent a significant milestone within the field of biomedical imaging. They not only reinforce the potential of THz imaging in revealing cochlear structures but also emphasize its adaptability and applicability across various medical disciplines. With its non-invasive, high-resolution capabilities, THz technology stands poised to redefine standards in medical imaging and diagnostics, offering hope for more effective interventions in hearing loss and other related conditions.

These achievements mark a critical advancement in the pursuit of effective diagnosis and treatment for hearing ailments, particularly in aging populations. As researchers continue to refine THz imaging methodologies, the hope is to increase accessibility and integration of this technology within clinical settings. The impact of such innovations on healthcare could substantially improve the quality of life for individuals affected by auditory disorders and further our understanding of the complexities of human biology.

The ongoing research and development of THz imaging technology signal a promising future for non-invasive medical diagnostics. This cutting-edge approach may soon revolutionize our understanding of not only the cochlea but also numerous other biological structures and diseases, opening doors to improved detection, better patient outcomes, and groundbreaking therapeutic options.

As the scientific community continues to explore the vast potential of terahertz imaging, it becomes increasingly clear that this technology is not merely a concept but a tangible tool with the ability to transform medical diagnostics fundamentally. Embracing these advancements will require collaboration, innovation, and a shared vision toward enhancing the future of healthcare.

Through continual research and commitment to advancements in medical imaging, a new paradigm emerges wherein challenges associated with traditional diagnostic methods are efficiently addressed, ensuring that those in need have access to precise and timely interventions.

With the era of THz imaging on the horizon, the medical community stands on the brink of transformative breakthroughs that will undoubtedly reshape our understanding of health and disease, paving the way for a future defined by enhanced diagnostic capabilities and a deeper comprehension of the intricacies of human physiology.

Subject of Research: Terahertz imaging of cochlear structures
Article Title: Three-dimensional terahertz near-field imaging evaluation of cochlea
News Publication Date: March 27, 2025
Web References: Optica Journal
References: DOI: 10.1364/OPTICA.543436
Image Credits: Dr. Kazunori Serita from Waseda University

Keywords: Terahertz imaging, cochlear structures, medical diagnostics, 3D reconstruction, non-invasive imaging, hearing loss, biomedical imaging, machine learning, pathology, oncology.